Crossmark

Is Cystatin C Good Enough as a Biomarker for Vancomycin Dosing: A Pharmacokinetic Perspective

Crossref DOI link: https://doi.org/10.1007/s13318-019-00587-3

Published Online: 2019-11-06

Published Print: 2020-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Guo

Li, Guo-Fu https://orcid.org/0000-0002-4628-9941
License Information

Text and Data Mining valid from 2019-11-06

Version of Record valid from 2019-11-06
More Information

Article History

First Online: 6 November 2019

Compliance with Ethical Standards

:

: No funding was used for this work.

: The authors have no conflicts of interest to declare.